FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075188 [Registered on: 14/10/2024] Trial Registered Prospectively
Last Modified On: 04/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Exploring the effectiveness of combined Ayurvedic treatment protocol for the management of Pushpaghni Jataharini (Polycystic Ovary Syndrome) 
Scientific Title of Study   Evaluation of the clinical efficacy of multimodal Ayurvedic treatment protocol in the management of Pushpaghni Jataharini (Polycystic Ovary Syndrome): An Exploratory Study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Veena Lalwani 
Designation  PG Scholar 
Affiliation  All India Institute of Ayurveda 
Address  7th Floor, Room No 725, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South

South
DELHI
110076
India 
Phone  9584751297  
Fax    
Email  veenalalwani011@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Santosh Kumar Bhatted 
Designation  Professor 
Affiliation  All India Institute of Ayurveda 
Address  Room no. 703, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South

South
DELHI
110076
India 
Phone  9414048459  
Fax    
Email  santoshbhatted@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Santosh Kumar Bhatted 
Designation  Professor 
Affiliation  All India Institute of Ayurveda 
Address  Room no. 703, Department of Panchakarma, Academic Block, All India Institute of Ayurveda, Gautampuri, Sarita Vihar, Delhi South

South
DELHI
110076
India 
Phone  9414048459  
Fax    
Email  santoshbhatted@rediffmail.com  
 
Source of Monetary or Material Support  
All India Institute of Ayurveda,Gautampuri Awas, Sarita Vihar,Delhi South, 110076,India 
 
Primary Sponsor  
Name  All India Institute of Ayurveda 
Address  7th Floor, Department of Panchakarma, Academic Block, All India Institute of Ayurveda,Gautampuri Awas,Sarita Vihar,Delhi 110076,India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Veena Lalwani  All India Institute of Ayurveda  OPD No. 6, Department of Panchakarma, Gautampuri Awas, Sarita Vihar, Delhi South,110076, India
South
DELHI 
9584751297

veenalalwani011@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Division of Translational Research and Biostatistics, All India Institute of Ayurveda, Delhi South, 110076  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E282||Polycystic ovarian syndrome. Ayurveda Condition: ARTAVADOSHAH/ARTAVADUSHTIH/RAJODOSHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-udvartanam, उद्वर्तनम् (Procedure Reference: Sushru samhita chikitsa sthana chapter 24 verse 51, Procedure details: Approx. 30 minutes in morning time for 3 days.)
(1) Medicine Name: Kolakulathadi churna, Reference: Charak sutrasthana chapter 3 verse 18, Route: Topical, Dosage Form: Churna/ Powder, Dose: 300(g), Frequency: od, Duration: 3 Days
2Intervention ArmProcedure-Sarvang bashpa swedana (Procedure Reference: Sushrut samhita chikitsa sthana chapter 32 verse 5-11, Procedure details: Till samyak swedana lakshana appears (till proper perspiration occurs))
(1) Medicine Name: Dashmool Kwath, Reference: Bhaishajya Ratnawali, Route: Topical, Dosage Form: Kwatha/Kashaya, Dose: 100(g), Frequency: od, Duration: 3 Days
3Intervention ArmDrugClassical(1) Medicine Name: Vaishvanar Churna, Reference: Ashtang Hrudaya Chikitsa sthana chapter 14 verse 34, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Days, anupAna/sahapAna: Yes(details: warm water), Additional Information: For deepana pachana
4Intervention ArmProcedure-Koshtashodhana (Procedure Reference: Sharangdhara samhita uttarkhand chapter 4 verse 5, Procedure details: Given in the morning for one day only. )
(1) Medicine Name: Gandharvhasta erand taila, Reference: Ashtang sangraha chikitsa sthana chapter 15 verse 21, Route: Oral, Dosage Form: Taila, Dose: 15(ml), Frequency: od, Duration: 1 Days
5Intervention ArmProcedure-anuvAsana-bastiH, अनुवासन-बस्तिः (Procedure Reference: Kashyap samhita sidhi sthana chapter 7, Procedure details: It will be given in morning time between 9am -12 pm after taking some food on 1,3,5,7,8 th day of yoga basti.)
(1) Medicine Name: Vidangadi taila anuvasana basti, Reference: Sushrut samhita chikitsa sthan chapter 37 verse 39-42, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 5 Days
6Intervention ArmProcedure-AsthApana-bastiH/ nirUha-bastiH, आस्थापन-बस्तिः/ निरूह-बस्तिः (Procedure Reference: Charak sidhi chapter 1 verse 38-41, Procedure details: It will be given in morning time between 8am -11 am, empty stomach on 2,4,6 th day of yoga basti.)
(1) Medicine Name: Bhadradi Kwath niruha basti, Reference: sushrut samhita chikitsa sthana chapter 38 verse 60-63, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 420(ml), Frequency: od, Duration: 3 Days
7Intervention ArmProcedure-nasyam/ nastam, नस्यम्/ नस्तम् (Procedure Reference: Charak sidhi chapter 2 verse 22, Procedure details: It will be given after 15 days of rest period after yoga basti.)
(1) Medicine Name: Kalyanak ghrita , Reference: Charak sidhi chapter 9 verse 35-41, Route: Nasal, Dosage Form: Ghrita, Dose: 2(ml), Frequency: od, Duration: 7 Days
8Intervention ArmDrugClassical(1) Medicine Name: Hingwashtak Churna, Reference: Bhaishjya ratnawali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Sabhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Ghrit), Additional Information: -
9Intervention ArmDrugClassical(1) Medicine Name: Dashmool kwath, Reference: Bhaishjya ratnawali, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 30 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1.Reproductive Age Group: 16-40 years (both married/unmarried).
2.Patients with clinical features of PCOS like-
• Amenorrhea or Oligomenorrhoea
• Infertility
• Anovulation
• Acne
• Hirsutism
• Acanthosis nigricans
3. Along with confirmed any one Polycystic Ovary in USG finding.
4. Patients fit for Basti and Nasya karma.
5. ICD - 11 Code: 5A80.1 Polycystic ovary syndrome
 
 
ExclusionCriteria 
Details  1. Primary amenorrhoea.
2. Pregnancy
3. Pelvic diseases like (Endometriosis, Hydrosalphinx, Fibroid uterus etc) causing Oligomenorrhoea and Anovulation.
4. Organic lesions of reproductive tract like T.B, Carcinoma and congenital deformities.
5. Hyperprolactenemia due to Pituitary Adenoma.
6. Cushing’s syndrome
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effect of Ayurvedic treatment protocol on –
1.Polycystic ovaries in USG findings (in unmarried).
2.Follicular growth and ovulation (in married).

 
0th day and 64th day (after shaman chikitsa) 
 
Secondary Outcome  
Outcome  TimePoints 
Relief in menstrual irregularities.
• Recovery of the Acne, Hirsutism, Acanthosis nigricans, BMI, Weight reduction.
• Improvement in quality of the life using PCOS QOL scale.
 
0th day, 34th day, 64th day, 94th day 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

RESEARCH QUESTION :

What is the effect of Multi-modal Ayurvedic Treatment Protocol in the management of Polycystic Ovary Syndrome (PCOS)?

 

HYPOTHESIS :

NULL HYPOTHESIS : (H0)           

There is no effect of Multi-modal Ayurvedic Treatment Protocol (Udvartana with Kolakulathadi Churna, Sarvang Bashpa Swedana with Dashmool Kwath and Pachana with Vaishvanar Churna , followed by Koshta Shudhi with Gandharvhasta Taila followed by Yoga Basti with Bhadradi Kwath and Vidangadi Taila followed by Nasya with Kalyanaka Ghrita followed by Shamana Chikitsa with Hingvashtak Churna and Dashmool Kwath) in the management of Pushpaghni Jataharini (Polycystic Ovary Syndrome).

 

ALTERNATE HYPOTHESIS : (H1)

There is significant effect of Multi-modal Ayurvedic Treatment Protocol (Udvartana with Kolakulathadi Churna, Sarvang Bashpa Swedana with Dashmool Kwatha and Pachana with Vaishvanar Churna, followed by Koshta Shudhi with Gandharvhasta Taila followed by Yoga Basti with Bhadradi Kwath  and Vidangadi taila followed by Nasya with Kalyanaka Ghrita followed by Shamana Chikitsa with Hingvashtak Churna and Dashmool Kwath) in the management of  Pushpaghni Jataharini (Polycystic Ovary Syndrome).


NEED OF THE STUDY

1.     Polycystic ovarian syndrome is a most prevalent endocrinopathy. Now a days because of sedentary lifestyles, incidence of this disease is very high. High prevalence not only among reproductive age, but also among adolescents.

2.     Patients with PCOS are at risk of developing Hypertension, Diabetes mellitus, obesity, anovulation and Infertility, Endometrial carcinoma, cardiovascular disease. 20% of women with PCOS develops non-insulin dependent diabetes mallitus (NIDDM) by the age of 30 years11.

3.     No permanent treatment is found for PCOS in modern therapy. The treatment given is symptomatic and duration remains for a longer period. The treatment module includes oral contraceptive, hormonal supplementation, ovulation induction drugs, antiestrogenic etc., which given for long term can produce severe ill effects on the body. Surgical drilling is one of the treatments given, but even its effect is also temporary.

4.     Application of Ayurvedic principles on the pathology involved, reveal a distinct vitiation of Vata. As it is the motive force behind the function of elimination or retention of mala, mutra, artava. Vata can be possibly normalized using the gold standard of Vata treatment – the ‘Basti Chikitsa’. Nasya (intranasal drug therapy) is known to be highly efficient on the central nervous system and regulate the H-P-O Axis, which is dysregulated in PCOS.

5.     Many clinical studies have been conducted to evaluate the efficacy of various aspects of Ayurvedic drugs and panchakarma procedures in the management of PCOS. But hardly an attempt is made for making an effective Ayurvedic Treatment Protocol that is both effective and safe in the management of PCOS. Thus making this study a novel. Hence the proposed study has been planned to establish a fix standard Ayurvedic treatment protocol.

6.     Due to limitation of medical therapy as well as surgical interventions, it becomes the necessity of time to find out a permanent, easy, effective and less side effect producing care which can be easily administered and accepted by the patient. The reason we are doing this research is to develop safe, non invasive, conservative and non hormonal treatment for PCOS.


AIMS & OBJECTIVES:

 AIM :-

· To establish an Ayurvedic standard treatment protocol for management of PCOS.

OBJECTIVES :-

PRIMARY OBJECTIVE  

To evaluate the effect of Ayurvedic treatment protocol on –

§     Polycystic ovaries in USG findings (in unmarried).

§     Follicular growth and ovulation (in married).

SECONDARY OBJECTIVE

To estimate the combined effect of Ayurvedic treatment protocol on -

â–ª Menstrual irregularities.

â–ª On the recovery of Acne, Hirsutism, Acanthosis nigricans, BMI, Weight reduction.

â–ª Improvement of quality of the life (PCOS QOL)

EXECUTION OF THE PROPOSED CLINICAL STUDY STUDY

STUDY TYPE: Non Randomized Clinical Trial

STUDY DESIGN: Interventional study

GROUPING: Single Arm

MASKING: Open Label

TIME: Prospective

STUDY SETTING: The OPD’s and IPD’s of AIIA

SAMPLE POPULATION: Patients from institutional hospital 

CONCEALMENT: Through Registration / UHID NO

SAMPLE SIZE CALCULATION:

Ø Study aims to see the positive changes based on USG in the patients of PCOS due to Ayurvedic Treatment Protocol proposed.

Ø  It is believed, since Panchakarma procedures are the part of the protocol, positive developments will definitely occur and it is assumed that in 80% of the cases positive improvement may occur.

Ø Assuming- Power of  Test as 80%, Level of Significance as 5% and one-sided test, the calculated sample size is 17. Assuming 10% dropouts study should include 20 patients.

Ø

 INCLUSION CRITERIA

1.     Reproductive Age Group: 16-40 years (both married/unmarried).

2.     Patients with clinical features of PCOS like-

 â€¢ Amenorrhea or Oligomenorrhoea  

• Infertility

ʉۢ Anovulation

ʉۢ Acne

ʉۢ Hirsutism

ʉۢ Acanthosis nigricans

3.     Along with confirmed any one Polycystic Ovary in USG finding.

4.     Patients fit for Basti and Nasya karma.

5.     ICD - 11 Code:   5A80.1 Polycystic ovary syndrome

 

EXCLUSION CRITERIA

1.     Primary amenorrhoea.

2.     Pregnancy

3.     Pelvic diseases like (Endometriosis, Hydrosalphinx, Fibroid uterus etc) causing Oligomenorrhoea and Anovulation.

4.     Organic lesions of reproductive tract like T.B, Carcinoma and congenital deformities.

5.     Hyperprolactenemia due to Pituitary Adenoma.

6.     Cushing’s syndrome

 

DIAGNOSTIC CRITERIA-

 Rotterdam criteria 2003 (2 out of 3 symptoms if present)

1. Anovulation or Oligo-ovulation .

2. Hyperandrogenism-

a) Clinical -Acne, Hirsutism, Acanthosis Nigricans

b) Biochemical- (elevated S.testosterone ).

3.  PCOS features on USG (  12 Follicles of 2- 9mm in size in each ovary  or ovarian volume >10 cc.)



STUDY DURATION

         Procedure

           Drug

    No. of Days

Udavartana 

Bashpa Swedana


Pachana

KolaKulathadi Churna

  3 Days

Dashmool Kwath

Vaishvanar Churna

Kostha Shuddhi

Gandharvhasta Taila

  1 Day

 

 

 

Yoga Basti

(8 Days)

 

Anuvasana Basti

 

 Vidangadi Taila (60 ML) + Saindhav 1g + Shatpushpa 1g

 For 5 Days (On 1,3,5,7,8th day)

 

Niruha Basti

 

 

Bhadradi Niruh Basti (420 ML)

 

Madhu                                                  -       90 ml                                                                                            

Saindhava                                             -       5 g

Sneha – Sarshap Taila , Tila Taila        -      60 ml

Kalka                                                    -      30 g

Kwath                                                   -      180 ml

Prakshep dravya- Yava kshar               -       5 g                                                                                          

Gomutra, Amla (Kaanji)                      -       50 ml

Day1

Day2

Day3

Day4

Day5

Day6

Day7

Day8

AB

NB

AB

NB

AB

NB

AB

AB

AB- Anuvasana Basti                              NB- Niruha Basti

 

 

For 3 Days

(On 2,4,6th day)

 

 

 

     Rest Period

                                            _

 

  15 Days

       Nasya

            Kalyanaka Ghrita

   7 Days

Shamana Chikitsa

  1. Hingvashtak churna
  2. Dashmool Kwath

  30Days

Follow up

                                                   _

  30 Days

 

 

·       Duration of Intervention – 64 Days

·       Duration of Follow Up – 30 Days

·       Total Duration of Clinical Study– 94 Days

 

 

INVESTIGATION –

     INVESTIGATION

           BT

         AT (After shaman chikitsa)

URINE PREGNANCY TEST

ü   

 

CBC WITH ESR

ü   

 

BLOOD SUGAR

Ø  FASTING

Ø  POSTPRANDIAL

ü   

 

SERUM FSH

ü   

ü   

SERUM LH

ü   

ü   

LH : FSH

ü   

ü   

SERUM PROLACTINE

ü   

 

SERUM FASTING INSULIN

ü   

ü   

THYROID FUNCTION TEST

ü   

 

U.S.G. (PELVIS / TVS )

ü   

ü   

 *Blood investigations will be done on 2nd or 3rd day of menstrual cycle.

Ultrasonography:

·       USG-Trans-vaginal (TVS)  in married patients.

·       USG-Pelvis in unmarried patients.

USG protocol adopted for the study:

1. USG will be done on 2nd or 3rd day of menses for diagnosis of PCO.

2. USG for follicular growth, maturity and ovulation will be done on alternate days from

09th to 19th  day.

CRITERIA FOR ASSESSMENT

Assessment has done based on both subjective and objective parameters.

Subjective Parameters:

The improvement in the patient was assessed mainly on the basis of relief in the signs and symptoms of PCOS like Menstrual pattern (duration, interval, amount of blood loss), Hirsutism, Acanthosis nigricans, Acne, BMI, Weight Reduction.

Objective Parameters:

• USG (Pelvis/TVS)

• Hormonal Assay

• Reduction in the ovarian volume .

• Ovulation, improvement in growth and development of follicle.

 
Close